Genmab — Maj 2020

[bikube]

Kursen i U S har lige været i + nu i 0 ved kurs 29,40. Regn selv om til DK.

[StockBull]

ja 29.34 nu på SAXO

[bibob]

Stadig over kurs 2000

[E_L]

Helge, the algo you referred to must have been written in Danish; it doesn't work in the US

[Helge_LarsenPI-redaktør]

E L:

[bikube]

Begge kurser (både Gmab og $) falder, så nu 1984Dkk.

[transalp]

Go morgen..

[Mogan]

God morgen

[JKY_VH]

God norgen;-)

[JKY_VH]

morgen

[bibob]

God morgen.

[bibob]

Gad vide om der er nogen der tør være ude af Genmab til den lange weekend.

[transalp]

Bob

[transalp]

Det lyder som helt ua

[transalp]

S

[transalp]

Nsvarlig tanke.. hahaha

[bibob]

Er du begyndt på den lange weekend Transalp.

[bibob]

Mateos Spotlights significance of sub Daratumumab approval in Myeloma. https://www.onclive.com/web-exclusives/mateos-spotlights-significance-of-subcutaneous-daratumumab-approval-in-myeloma?eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

[E_L]

so she clearly states what some have asked; After the first administration with the subcutaneous formulation, [the patient] can stay around the hospital, around the facility, for approximately 2 or 3 hours in order to see whether they develop any IRRs

[E_L]

This is only applicable to the first infusion and if no IRR is observed at that time, the patient can immediately leave after administration [come] the second infusion.